{"Our": [0], "objective": [1], "was": [2], "to": [3, 33, 83], "update": [4], "the": [5, 9, 104, 177], "EULAR": [6], "recommendations": [7, 131, 167], "for": [8, 135, 148], "management": [10, 178], "of": [11, 54, 96, 106, 179], "systemic": [12], "lupus": [13], "erythematosus": [14], "(SLE),": [15], "based": [16], "on": [17, 176], "emerging": [18], "new": [19], "evidence.": [20], "We": [21], "performed": [22], "a": [23, 65], "systematic": [24], "literature": [25], "review": [26], "(01/2007-12/2017),": [27], "followed": [28], "by": [29], "modified": [30], "Delphi": [31], "method,": [32], "form": [34], "questions,": [35], "elicit": [36], "expert": [37], "opinions": [38], "and": [39, 52, 139, 154, 159, 170, 183], "reach": [40], "consensus.": [41], "Treatment": [42], "in": [43, 59, 125], "SLE": [44, 144], "aims": [45], "at": [46, 64], "remission": [47], "or": [48, 111], "low": [49], "disease": [50], "activity": [51], "prevention": [53], "flares.": [55], "Hydroxychloroquine": [56], "is": [57], "recommended": [58], "all": [60], "patients": [61, 171], "with": [62, 143, 172], "lupus,": [63], "dose": [66], "not": [67], "exceeding": [68], "5": [69], "mg/kg": [70], "real": [71], "body": [72], "weight.": [73], "During": [74], "chronic": [75], "maintenance": [76], "treatment,": [77], "glucocorticoids": [78], "(GC)": [79], "should": [80, 117, 145], "be": [81, 118, 123, 146, 162], "minimised": [82], "less": [84], "than": [85], "7.5": [86], "mg/day": [87], "(prednisone": [88], "equivalent)": [89], "and,": [90], "when": [91], "possible,": [92], "withdrawn.": [93], "Appropriate": [94], "initiation": [95], "immunomodulatory": [97], "agents": [98], "(methotrexate,": [99], "azathioprine,": [100], "mycophenolate)": [101], "can": [102], "expedite": [103], "tapering/discontinuation": [105], "GC.": [107], "In": [108], "persistently": [109], "active": [110], "flaring": [112], "extrarenal": [113], "disease,": [114], "add-on": [115], "belimumab": [116], "considered;": [119], "rituximab": [120], "(RTX)": [121], "may": [122], "considered": [124], "organ-threatening,": [126], "refractory": [127], "disease.": [128, 141], "Updated": [129], "specific": [130], "are": [132], "also": [133], "provided": [134], "cutaneous,": [136], "neuropsychiatric,": [137], "haematological": [138], "renal": [140], "Patients": [142], "assessed": [147], "their": [149], "antiphospholipid": [150], "antibody": [151], "status,": [152], "infectious": [153], "cardiovascular": [155], "diseases": [156], "risk": [157], "profile": [158], "preventative": [160], "strategies": [161], "tailored": [163], "accordingly.": [164], "The": [165], "updated": [166, 173], "provide": [168], "physicians": [169], "consensus": [174], "guidance": [175], "SLE,": [180], "combining": [181], "evidence-base": [182], "expert-opinion.": [184]}